- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
Statement
In large clinical trials conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for mechanical ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With...
Showing 10 out of 1847 results
|
NHLBI in the Press
Scientists discover how the immune pathway complement is activated and can be inhibited following SARS-COV-2 infection.
|
NHLBI in the Press
Clinical researchers detail the role biological sex and gender have in shaping disease risk and outcomes in 11 medical conditions, including COVID-19.
Credit: Stephanie King, University of Michigan
|
NHLBI in the Press
NHLBI-supported researchers are reporting that COVID-19 triggers the production of certain autoimmune antibodies in the blood and that these antibodies are the culprit behind the formation of potentially life-threating blood clots in people hospitalized with the disease.
Credit: Courtesy of NIH Medical Arts
|
News Release
Targeting cell’s ‘trash compactor’ could lead to new antiviral strategy to fight COVID-19 Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body. A better understanding of this important pathway may provide vital insight...
Credit: NIH Medical Arts
|
NHLBI in the Press
Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body.
|
NHLBI in the Press
Two Boston hospital patient registries show women ages 50 and younger are less likely to have a heart attack compared to men the same age, but they have higher death rates a decade later.
|
NHLBI in the Press
Scientists finalized the Genotype-Tissue Expression project, which characterizes thousands of genetic variants in 49 tissue types from 838 donors.
|
NHLBI in the Press
A study profiles the metabolic preferences of human hearts, which supports future research to prevent and treat heart failure.
|
Research Feature
Peter Libby, M.D., never imagined nearly 40 years ago that his research would contribute to the current understanding of how the novel coronavirus targets and ravages the blood vessels in people with COVID-19. In the 1980s, Libby, then an assistant professor of medicine at Tufts University School of Medicine, was the first to discover that arterial...
|
Research Feature
Could bring improved diagnostics and treatments for dementia, stroke, brain trauma, and more The blood-brain barrier has been called one of neurology’s greatest challenges. The thin, selectively permeable membrane acts almost like plastic wrap, protecting the brain tissue from dangerous pathogens and toxins in the blood. In short, it maintains the...